SOPH (Sophia Genetics) Tariff Resilience Score: 8/10 (As of Jul. 05, 2026)


SOPH Sophia Genetics SA SOPH
73 GF Score
Price $5.36
GF Value $5.04
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Sophia Genetics Tariff Resilience Score?

Sophia Genetics SOPH -4.12% 73 Tariff Resilience Score is 8 as of Jul. 05, 2026. GuruFocus rates SOPH with a GF Score™ of 73/100 and a GF Value™ of $5.04 (Fairly Valued). The stock has 6 warning signs investors should review. Among 672 Healthcare Providers & Services companies, Sophia Genetics ranks better than 96.58% on this metric.

Sophia Genetics has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Sophia Genetics has Genomics company with minimal tariff exposure due to digital product offerings and localized operations. Global partnerships and diversified supply chain enhance resilience. Historical tariff impacts negligible, with strong mitigation strategies.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Sophia Genetics might have Highly Resilient.

Sophia Genetics  (NAS:SOPH) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Sophia Genetics Tariff Resilience Score Related Terms

SOPH vs WEAV, NRC, MDRX: Tariff Resilience Score Comparison

For the Health Information Services subindustry, Sophia Genetics's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sophia Genetics Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sophia Genetics's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Sophia Genetics's Tariff Resilience Score falls into.


SOPH
73GF Score
Sophia Genetics SA SOPH
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
Sophia Genetics (SOPH) has a Tariff Resilience Score of 8 as of Jul. 05, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Sophia Genetics ranks #23 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 3.4%.
Is Sophia Genetics' Tariff Resilience Score too high?
Sophia Genetics' current Tariff Resilience Score is 8. Based on the distribution chart, Sophia Genetics ranks #23 out of 672 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Sophia Genetics has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sophia Genetics' Tariff Resilience Score compare to WEAV and NRC?
According to the Healthcare Providers & Services industry distribution chart, Sophia Genetics ranks #23 out of 672 companies for Tariff Resilience Score. This places Sophia Genetics in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Sophia Genetics's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sophia Genetics stock overvalued right now?
Based on GuruFocus' analysis, Sophia Genetics (SOPH) is currently considered Fairly Valued. The stock's GF Value™ is $5.04, compared to a current price of $5.36 — trading 6.3% above its estimated fair value. The current Tariff Resilience Score is 8. Sophia Genetics' overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Sophia Genetics (SOPH), the current Tariff Resilience Score is 8 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sophia Genetics (SOPH) Overvalued in 2026?

Based on GuruFocus' analysis, Sophia Genetics stock appears to be overvalued. The current stock price of $5.36 is trading 6.3% above its estimated GF Value™ of $5.04. GuruFocus considers Sophia Genetics to be Fairly Valued.

Key valuation signals for SOPH:

  • Tariff Resilience Score: 8
  • GF Value™: $5.04 vs. price of $5.36 (6.3% above fair value)
  • GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the SOPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sophia Genetics Business Description

Other Exchanges 90B:Germany
Address La Piece 12, Rolle, CHE, CH-1180
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
73GF Score

Get the complete analysis for SOPH

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.36
Price
$5.04
GF Value